View Article

  • Role of HPLC in Quality Control Testing of Pharmaceuticals: A Regulatory Perspective

  • Smt. Sharadhchandrika Suresh Patil College of Pharmacy, Chopda, Jalgaon 425107

Abstract

High-Performance Liquid Chromatography (HPLC) is a cornerstone analytical technique in the pharmaceutical industry, playing a critical role in ensuring product quality, safety, and regulatory compliance. This study examines the significance of HPLC within the framework of global regulatory standards established by agencies such as the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), and the International Council for Harmonisation (ICH). Emphasis is placed on the application of HPLC for assessing the purity, potency, identity, and stability of active pharmaceutical ingredients (APIs) and finished dosage forms. The abstract also underscores the essential method validation parameters—including accuracy, precision, specificity, linearity, limit of detection (LOD), limit of quantification (LOQ), and robustness—that are required to meet regulatory expectations. A comparative evaluation of international guidelines and selected case studies further demonstrates how HPLC facilitates robust quality control strategies throughout the drug development and manufacturing lifecycle. As regulatory frameworks evolve toward more stringent quality standards, HPLC continues to serve as a dependable, versatile, and indispensable analytical tool in pharmaceutical quality assurance.

Keywords

Precision, Linearity, Chromatographic analysis, Analytical Lifecycle, Regulatory Submission, Compliance, HPLC Instrumentation, Method Optimization

Introduction

Why These Matters from a Regulatory Perspective:

Regulatory Significance:

  • Ensures that analytical method results are reliable, reproducible, and consistent across production batches, aligning with Good Manufacturing Practice (GMP) documentation standards.
  • Provides validated and defensible data demonstrating the drug’s purity, potency, and stability, in accordance with regulatory expectations from agencies such as the FDA and EMA.
  • Confirms the scientific rigor and adaptability of analytical methods—particularly through the principles of Analytical Quality by Design (AQbD)—supporting method lifecycle management and continuous improvement. [1]
  • Minimizes the risk of erroneous out-of-specification (OOS) results, thereby reducing unnecessary investigations, regulatory scrutiny, or potential batch rejections.

A range of analytical techniques is available for the evaluation of pharmaceutical compounds; however, High-Performance Liquid Chromatography (HPLC) is currently regarded as the preferred method. This technique is also referred to as High-Pressure Liquid Chromatography, emphasizing the elevated pressure applied during the process. While there is some debate over the term "high-performance," its usage in this context is widely accepted. [2]

In the pharmaceutical industry, HPLC serves a broad range of applications. It is routinely used to evaluate the purity of new drug candidates, to monitor changes during synthetic processes, to support in-process testing during formulation development, and to conduct quality control and assurance of the final drug products.[3]

 OBJECTIVE:

This paper aims to present a comprehensive review of the role of High-Performance Liquid Chromatography (HPLC) in the quality control testing of pharmaceutical products, with particular emphasis on regulatory requirements and compliance. It explores the diverse applications of HPLC in pharmaceutical analysis, including method validation, impurity profiling, and content uniformity assessment. Additionally, the paper examines relevant regulatory guidelines and expectations set forth by major regulatory bodies, including the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), and the International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use (ICH).[4]

SCOPE:

This paper focuses on the critical role of High-Performance Liquid Chromatography (HPLC) in pharmaceutical quality control, with an emphasis on regulatory compliance and analytical reliability. The scope is defined across the following key areas[5]

1. Pharmaceuticals

The review examines the application of HPLC in the quality control of small-molecule pharmaceuticals, including both active pharmaceutical ingredients (APIs) and finished dosage forms. Particular attention is given to HPLC-based assessment of identity, purity, potency, dissolution behavior, impurity profiling, and stability-testing parameters that are essential for ensuring product quality throughout the drug lifecycle.[6]

2. Regulatory Agencies

This paper evaluates the regulatory expectations and analytical requirements set forth by major global health authorities, including:

  • The U.S. Food and Drug Administration (FDA)
  • The European Medicines Agency (EMA)
  • The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH)[7]

Emphasis is placed on guidelines related to analytical method development, validation, and lifecycle management, such as ICH Q2(R2), Q14, and FDA/EMA quality systems guidance. The discussion integrates how these regulatory frameworks guide the adoption and implementation of HPLC in routine and advanced pharmaceutical quality control.[8]

3. HPLC Techniques

The paper explores a comprehensive range of HPLC techniques used in pharmaceutical analysis, including:

  • Reversed-phase HPLC (RP-HPLC)
  • Normal-phase HPLC (NP-HPLC)
  • Hydrophilic Interaction Liquid Chromatography (HILIC)
  • Stability-indicating HPLC methods
  • Gradient and isocratic elution techniques[9]

In addition, it covers method development strategies such as mobile phase selection, column optimization, detection choices (UV, PDA, MS), and system suitability criteria. Method validation parameters—accuracy, precision, specificity, linearity, range, LOD, LOQ, robustness, and ruggedness—are also discussed in alignment with regulatory standards.[10]

HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY (HPLC)

HPLC is an advanced analytical technique that employs liquid chromatography and specialized columns to separate, identify, quantify, and analyze active components within complex mixtures. Compared to traditional chromatographic methods, HPLC offers significantly enhanced performance in terms of efficiency and resolution. This improvement is largely attributed to the use of stationary phases composed of uniformly sized spherical particles, typically ranging from 2 to 5 µm in diameter. The small particle size results in increased resistance to flow, thereby requiring the mobile phase to be pushed through the column under high pressure. Consequently, the technique is referred to as high-pressure or high-performance liquid chromatography. [11]

Importance of HPLC in Pharmaceutical Quality Control

High-Performance Liquid Chromatography (HPLC) is a vital analytical tool in pharmaceutical quality control. It ensures the accuracy, purity, and consistency of drug products by detecting and quantifying active ingredients and impurities. HPLC is essential in stability studies, batch consistency checks, and validation of manufacturing processes. Due to its precision and reliability, it is widely accepted by global regulatory agencies for routine QC testing across various dosage forms.[12]

Regulatory Compliance: Guidelines for Pharmaceutical HPLC

High-Performance Liquid Chromatography (HPLC) is a cornerstone analytical method in the pharmaceutical sector, which is governed by stringent regulatory standards. Compliance with these regulations is essential to ensure product safety, efficacy, and quality. [13]

  1. ICH Guidelines :-

The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) provides comprehensive directives for validating HPLC methods. These standards cover critical parameters such as accuracy, precision, specificity, linearity, and robustness. Additionally, ICH guidelines set forth permissible impurity levels in active pharmaceutical ingredients (APIs) and finished drug products. [14]

  1. FDA and EMA Standards :-

Regulatory bodies like the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) recognize HPLC as a fundamental tool for drug analysis. Any regulatory submission must include well-validated HPLC methods to substantiate claims regarding the drug's identity, purity, potency, and stability. [15]

  1. Good Manufacturing Practices (GMP) :-

HPLC instruments used in pharmaceutical analysis must comply with Good Manufacturing Practice (GMP) protocols. This includes routine equipment calibration, conducting system suitability tests, and maintaining comprehensive and accurate records of all analytical procedures.[16]

METHODOLOGY 

Fundamentals of HPLC (High-Performance Liquid Chromatography)

Principles of Chromatography and HPLC

Chromatography is an analytical technique used to separate, identify, and quantify components within a mixture. High-Performance Liquid Chromatography (HPLC) is a specialized form of chromatography that utilizes a liquid mobile phase to carry the sample through a column packed with a stationary phase. The separation occurs based on the differing interactions of each component with the stationary and mobile phases. [17]

In HPLC, components that have a stronger affinity for the stationary phase are retained longer in the column, while those with weaker interactions elute more quickly. This difference in retention time allows for the effective separation of mixture components, which is governed by their distribution coefficients between the two phases. [18]

Key Components of an HPLC System:

Solvent Reservoir: Stores the mobile phase (liquid solvent).

Pump: Delivers the mobile phase at high pressure through the column.

Injector: Introduces the sample into the flowing mobile phase.

Column: Contains the stationary phase and performs the actual separation.

Detector: Identifies and measures the separated compounds as they elute from the column.[19]

Types of HPLC Modes and Their Applications

HPLC can be operated in various modes, depending on the nature of the sample and the required separation:

  1. Reversed-Phase HPLC (RP-HPLC):

Stationary Phase: Non-polar

Mobile Phase: Polar

Application: Widely used for separating non-polar to moderately polar compounds such as pharmaceuticals, pesticides, and peptides.

  1. Normal-Phase HPLC (NP-HPLC):

Stationary Phase: Polar

Mobile Phase: Non-polar

Application: Suitable for the separation of polar compounds such as sugars, small polar molecules, and certain drugs.

  1. Ion Exchange HPLC (IEC):

Stationary Phase: Ion-exchange resin (charged surface)

Application: Used for the analysis of charged or ionic substances like amino acids, nucleotides, and inorganic ions.

  1. Size Exclusion HPLC (SEC):

Stationary Phase: Porous material

Application: Separates molecules based on size; commonly used for analyzing polymers, proteins, and other macromolecules. [20]

Table 1. Overview of HPLC Types, Principles, and Key Applications in Pharmaceutical Quality Assurance[21]

HPLC Types

Principle of HPLC

Key applications in Pharma QA

Reverse Phase (RP)

Hydrophobic (non-polar) interactions

API quantification, impurity profiling, dissolution

Normal Phase (NP)

Polarity differences

Seperation of polar compounds and isomers

Ion exchange

Charge differences (cation, anion interactions)

Analysis of ions, amino acids and charged impurities

Size Exclusion (SEC)

Molecular Size

Protein/ Aggregate analysis, polymer characterization

Affinity

Specific affinity interactions (biomolecules)

Bioanalysis, antibody captures, Biopharmaceuticals

Chiral

Chirality (enantiomer

separation)

Stereoisomer analysis in chiral drugs

HOW HPLC WORKS:

High-Performance Liquid Chromatography (HPLC) operates through a sequence of well-defined analytical steps that collectively enable the separation, detection, and quantification of chemical components in a mixture. The working principle of HPLC can be explained through the following stages[22]

1. Sample Introduction

The analytical sample is introduced into the flowing mobile phase, typically using an autosampler or manual injection via a microsyringe. This step ensures accurate, precise, and reproducible sample volumes, which are critical for quantitative reliability. The injected sample is carried toward the chromatographic column by the mobile phase.[23]

2. Chromatographic Separation

Inside the column, the sample components interact with the stationary phase to different extents based on their physicochemical properties.

  • Compounds with stronger interactions with the stationary phase exhibit longer retention times.
  • Compounds with weaker interactions elute earlier.[24]

This differential partitioning forms the basis of separation and depends on factors such as polarity, hydrophobicity, charge, and molecular size, depending on the type of HPLC technique used (RP-HPLC, NP-HPLC, Ion-exchange, etc.).[25]

3. Detection

After separation, analytes exit the column and enter the detector. The detector measures specific physical or chemical properties of each analyte, such as:

  • UV/Visible absorbance (most common)
  • Fluorescence
  • Refractive index
  • Mass-to-charge ratio (MS) in LC–MS systems

The detector converts these measurements into electrical signals proportional to the concentration of the analytes.[26]

4. Data Processing and Analysis

The electrical signals from the detector are converted into a chromatogram, which plots detector response (y-axis) versus retention time (x-axis).

  • Each peak corresponds to a separate compound.
  • Retention time provides qualitative identification.
  • Peak area or height is used for quantitative estimation.

Data evaluation software integrates peaks, calculates concentrations using calibration curves, and generates quantitative reports essential for pharmaceutical quality control.[27]

Table 2. Key Applications of HPLC in Pharmaceutical Analysis and Their Primary Objectives[28]

HPLC Application

Main Objective

Drug substance and product purity

Confirm API and excipient quality

Impurity Profiling

Safety  via detection/quantification of impurities

Content Uniformity

Consistent Dosage delivery

Drug Stability Studies

Assess shelf life and degradation

Dissolution profile analysis

Ensures therapeutic efficacy

Bioanalysis/ pharmacokinetics

Support clinical, bioequivalence studies

Case Study: HPLC Implementation in Pharmaceutical Quality Control Impurity

Profiling in Active Pharmaceutical Ingredients (APIs)                    

Scenario: An API manufacturer adopted HPLC with gradient elution to separate and quantify multiple impurities present in a single run.                    

Outcome: Streamlined QC process, reducing analysis time by 30%.

Successfully met regulatory requirements for impurity profiling and method validation.             

Green HPLC Method for Multi-Drug Analysis                    

Description: A pharmaceutical QC lab developed a novel, eco-friendly RP-HPLC method to simultaneously separate and quantify a mixture of piracetam, ketoprofen, and omeprazole in various dosage forms (tablets, capsules). The method used a gradient elution (methanol-water) that significantly minimized solvent use, reduced time, and lowered costs.  [31]                 

Regulatory Impact: Achieved robust method validation (accuracy, linearity, precision, specificity).                                                                                                 

Fulfilled regulatory guidelines (FDA, ICH, and USP) for simultaneous multi-component analysis.                                                                                             

Enhanced sustainability in the QC workflow while satisfying compliance requirements.

Additional Example:  Enhancing  Pharmaceutical QC with HPLC.

Context: A pharmaceutical lab applied HPLC assays for impurity profiling, dissolution testing, and assay validation of drug samples, demonstrating compliance with all relevant regulatory standards. Extensive validation and routine system suitability tests ensured audit readiness and regulatory acceptance.   [29,30]                                

CONCLUSION:

HPLC stands at the core of quality assurance and regulatory compliance in pharmaceuticals. Its regulatory-mandated use:

Enables precise impurity detection and quantification, Assures content uniformity and dosage accuracy, Monitors drug stability and product shelf life,  Fulfills validation and audit requirements critical to product approvals and patient safety.

Effectively implemented HPLC methods streamline compliance, mitigate regulatory risks, and uphold the highest standards of pharmaceutical quality.

REFERENCES

  1. Bhati, C., et al. (2022). High Performance Liquid Chromatography: Recent patents and advancement. Biomed Pharma Journal.
  2. Nikolin, B., et al. (2004). High Performance Liquid Chromatography in pharmaceutical analyses. Acta Pharmaceutica. (PMC7250120)
  3. Souri, E., et al. (2007). HPLC analysis of orlistat and its application to drug quality control studies. Journal of AOAC International. https://pubmed.ncbi.nlm.nih.gov/17268098/
  4. Caldicot, E. (2025). Advances in High Performance Liquid Chromatography (HPLC) techniques for pharmaceutical analysis: A comprehensive review. Journal of Analytical & Bioanalytical Techniques, 15(2), 1000617.
  5. Anonymous. (2025). Enhancing pharmaceutical quality control with HPLC: A case study. Journal of Pharmaceutical Quality Control. Available on Academia.edu.
  6. Anonymous. (2025). Enhancing pharmaceutical QC with HPLC. Pharmaceutical Quality Control Review. (Online article)
  7. Ahuja, S. (2005). Handbook of pharmaceutical analysis by HPLC. Elsevier.
  8. Zacharis, C. K. (2009). Accelerating the quality control of pharmaceuticals using monolithic stationary phases: A review of recent HPLC applications. Journal of Chromatographic Science, 47(6), 443–451. https://doi.org/10.1093/chromsci/47.6.443
  9. Chawla, G., & Chaudhary, K. K. (2019). A review of HPLC technique covering its pharmaceutical, environmental, forensic, clinical and other applications. International Journal of Pharmaceutical Chemistry and Analysis, 6(2), 27–39.
  10. Hussein, J. (2024). Principles and applications of high-performance liquid chromatography (HPLC): A review. Molecules, 29(6), 1346.
  11. Ali, A. H. (2022). High-performance liquid chromatography (HPLC): A review. Advance Chemistry Journal.
  12. Zacharis, C. K. (2009). Accelerating the quality control of pharmaceuticals using monolithic stationary phases: A review of recent HPLC applications. Journal of Chromatographic Science, 47(6), 443–451. https://doi.org/10.1093/chromsci/47.6.443
  13. Nikolin, B. (2004). High performance liquid chromatography in pharmaceutical analysis. (Unpublished/online source)
  14. Nikolin, B., Imamovi?, B., Medanhodži?-Vuk, S., & Sober, M. (2004). High performance liquid chromatography in pharmaceutical analyses. Acta Pharmaceutica. (PMC7250120)
  15. Caldicot, E. (2025). Advances in high performance liquid chromatography (HPLC) techniques for pharmaceutical analysis: A comprehensive review. Journal of Analytical & Bioanalytical Techniques, 15(2), 1000617.
  16. Anonymous. (2025). Enhanced pharmaceutical quality control with HPLC: A case study. Academia.edu.
  17. Anonymous. (2025). Revolutionizing stability-indicating analysis: Advanced RP-HPLC strategies for pharmaceutical excellence. Zenodo.
  18. Anonymous. (2025). HPLC applications in pharmaceuticals: Quality control and drug development. Mastelf.com.
  19. Bhati, C., et al. (2022). High performance liquid chromatography: Recent patents and advancement. Biomed Pharma Journal.
  20. Zacharis, C. K. (2009). Accelerating the quality control of pharmaceuticals using monolithic stationary phases: A review of recent HPLC applications. Journal of Chromatographic Science, 47(6), 443–451.
  21. Souri, E., et al. (2007). HPLC analysis of orlistat and its application to drug quality control. Journal of AOAC International. PMID: 17268098.
  22. Anonymous. (2025). Enhancing pharmaceutical quality control with HPLC: A case study. Journal of Pharmaceutical Quality Control. Available at Academia.edu.
  23. Anonymous. (2025). HPLC applications in pharmaceuticals: Quality control and drug development. Mastelf.com.
  24. Puri, N., et al. (2014). Analysis of complex pharmaceuticals by ultrahigh-pressure liquid chromatography: Case studies and quality control. LCGC North America.
  25. ALW Science. (2024). Case studies on HPLC vial issues. ALW Science Blog.
  26. PredictML.ai. (2025). AI-powered peak detection and integration in HPLC for drug quality assurance: A case study.
  27. Anonymous. (2025). Revolutionizing stability-indicating analysis: Advanced RP-HPLC strategies for pharmaceutical excellence. Zenodo.
  28. GMI Inc. (n.d.). GMI case study: KNAUER HPLC in real-world applications. G-M-I Inc.
  29. Anonymous. (2022). High Performance Liquid Chromatography: Theory, instrumentation and application in drug quality control (Vol. 6). Walter de Gruyter GmbH & Co KG.
  30. Fong, G. W. (Ed.). (1991). HPLC in the pharmaceutical industry. CRC Press.
  31. Anonymous. (2022). High Performance Liquid Chromatography: Theory, instrumentation and application in drug quality control. Walter de Gruyter GmbH & Co KG.

Reference

  1. Bhati, C., et al. (2022). High Performance Liquid Chromatography: Recent patents and advancement. Biomed Pharma Journal.
  2. Nikolin, B., et al. (2004). High Performance Liquid Chromatography in pharmaceutical analyses. Acta Pharmaceutica. (PMC7250120)
  3. Souri, E., et al. (2007). HPLC analysis of orlistat and its application to drug quality control studies. Journal of AOAC International. https://pubmed.ncbi.nlm.nih.gov/17268098/
  4. Caldicot, E. (2025). Advances in High Performance Liquid Chromatography (HPLC) techniques for pharmaceutical analysis: A comprehensive review. Journal of Analytical & Bioanalytical Techniques, 15(2), 1000617.
  5. Anonymous. (2025). Enhancing pharmaceutical quality control with HPLC: A case study. Journal of Pharmaceutical Quality Control. Available on Academia.edu.
  6. Anonymous. (2025). Enhancing pharmaceutical QC with HPLC. Pharmaceutical Quality Control Review. (Online article)
  7. Ahuja, S. (2005). Handbook of pharmaceutical analysis by HPLC. Elsevier.
  8. Zacharis, C. K. (2009). Accelerating the quality control of pharmaceuticals using monolithic stationary phases: A review of recent HPLC applications. Journal of Chromatographic Science, 47(6), 443–451. https://doi.org/10.1093/chromsci/47.6.443
  9. Chawla, G., & Chaudhary, K. K. (2019). A review of HPLC technique covering its pharmaceutical, environmental, forensic, clinical and other applications. International Journal of Pharmaceutical Chemistry and Analysis, 6(2), 27–39.
  10. Hussein, J. (2024). Principles and applications of high-performance liquid chromatography (HPLC): A review. Molecules, 29(6), 1346.
  11. Ali, A. H. (2022). High-performance liquid chromatography (HPLC): A review. Advance Chemistry Journal.
  12. Zacharis, C. K. (2009). Accelerating the quality control of pharmaceuticals using monolithic stationary phases: A review of recent HPLC applications. Journal of Chromatographic Science, 47(6), 443–451. https://doi.org/10.1093/chromsci/47.6.443
  13. Nikolin, B. (2004). High performance liquid chromatography in pharmaceutical analysis. (Unpublished/online source)
  14. Nikolin, B., Imamovi?, B., Medanhodži?-Vuk, S., & Sober, M. (2004). High performance liquid chromatography in pharmaceutical analyses. Acta Pharmaceutica. (PMC7250120)
  15. Caldicot, E. (2025). Advances in high performance liquid chromatography (HPLC) techniques for pharmaceutical analysis: A comprehensive review. Journal of Analytical & Bioanalytical Techniques, 15(2), 1000617.
  16. Anonymous. (2025). Enhanced pharmaceutical quality control with HPLC: A case study. Academia.edu.
  17. Anonymous. (2025). Revolutionizing stability-indicating analysis: Advanced RP-HPLC strategies for pharmaceutical excellence. Zenodo.
  18. Anonymous. (2025). HPLC applications in pharmaceuticals: Quality control and drug development. Mastelf.com.
  19. Bhati, C., et al. (2022). High performance liquid chromatography: Recent patents and advancement. Biomed Pharma Journal.
  20. Zacharis, C. K. (2009). Accelerating the quality control of pharmaceuticals using monolithic stationary phases: A review of recent HPLC applications. Journal of Chromatographic Science, 47(6), 443–451.
  21. Souri, E., et al. (2007). HPLC analysis of orlistat and its application to drug quality control. Journal of AOAC International. PMID: 17268098.
  22. Anonymous. (2025). Enhancing pharmaceutical quality control with HPLC: A case study. Journal of Pharmaceutical Quality Control. Available at Academia.edu.
  23. Anonymous. (2025). HPLC applications in pharmaceuticals: Quality control and drug development. Mastelf.com.
  24. Puri, N., et al. (2014). Analysis of complex pharmaceuticals by ultrahigh-pressure liquid chromatography: Case studies and quality control. LCGC North America.
  25. ALW Science. (2024). Case studies on HPLC vial issues. ALW Science Blog.
  26. PredictML.ai. (2025). AI-powered peak detection and integration in HPLC for drug quality assurance: A case study.
  27. Anonymous. (2025). Revolutionizing stability-indicating analysis: Advanced RP-HPLC strategies for pharmaceutical excellence. Zenodo.
  28. GMI Inc. (n.d.). GMI case study: KNAUER HPLC in real-world applications. G-M-I Inc.
  29. Anonymous. (2022). High Performance Liquid Chromatography: Theory, instrumentation and application in drug quality control (Vol. 6). Walter de Gruyter GmbH & Co KG.
  30. Fong, G. W. (Ed.). (1991). HPLC in the pharmaceutical industry. CRC Press.
  31. Anonymous. (2022). High Performance Liquid Chromatography: Theory, instrumentation and application in drug quality control. Walter de Gruyter GmbH & Co KG.

Photo
Sejal Mali
Corresponding author

Smt. Sharadhchandrika Suresh Patil College of Pharmacy, Chopda, Jalgaon 425107

Photo
Bhagyashree Bhalerao
Co-author

Smt. Sharadhchandrika Suresh Patil College of Pharmacy, Chopda, Jalgaon 425107

Bhagyashree Bhalerao, Role of HPLC in Quality Control Testing of Pharmaceuticals: A Regulatory Perspective, Int. J. of Pharm. Sci., 2025, Vol 3, Issue 12, 2608-2616. https://doi.org/10.5281/zenodo.17952125

More related articles
Gangrene: Early Detection, Emerging Therapies, and...
Faraz Pathan, Rubina Sheikh, Ayesha Siddiqua, Ashna Khan, Sana Ma...
Navigating the United States, Japan, Canada, Europ...
Munish Singla, Jaspreet Kaur, Dr. Parminder Nain, ...
A Review on Role of Nanoparticles in Targeted Drug...
Komal Pawar, Suchita Lathi, Pallavi Shnide, Vaishnavi Shinde, ...
Development and Validation of an RP-HPLC Method for Quantification of Levodopa i...
Santosh Kumar, Mangal Singh , Sarita , Manjeet Singh Yadav , ...
Quality Audit Challenges in Small-Scale Ayurvedic Manufacturing Units...
Akanksha Pagar, Ganesh Sonawane, Vijayraj Sonawane, Sunil Mahajan, Deepak Sonawane, ...
Related Articles
Analytical Quality by Design (AQbD): Principles, Tools and Case Studies...
Rasika Tilekar, Smita Waghmare, Neelam Bhagdewani, Prem Jadhav, Bhavana Galande, Pramod Ingale, ...
Role of Journal Clubs in Developing Critical Thinking and Evidence-Based Practic...
Anna John Viany, Lekshmipriya P S, Karthika Lal B, Jerin Annie Thomas, ...
Role of Botanicals in Alopecia Management, Mechanism of Ginger, Garlic, Clove an...
Mugdha Joshi, Prajwal Nimkarde, Vilasini Pandav, Manisha Kasar, Sukanya Kamane, ...
Gangrene: Early Detection, Emerging Therapies, and The Role of Artificial Intell...
Faraz Pathan, Rubina Sheikh, Ayesha Siddiqua, Ashna Khan, Sana Malik, Prerona Das, ...
More related articles
Gangrene: Early Detection, Emerging Therapies, and The Role of Artificial Intell...
Faraz Pathan, Rubina Sheikh, Ayesha Siddiqua, Ashna Khan, Sana Malik, Prerona Das, ...
A Review on Role of Nanoparticles in Targeted Drug Delivery Systems ...
Komal Pawar, Suchita Lathi, Pallavi Shnide, Vaishnavi Shinde, ...
Gangrene: Early Detection, Emerging Therapies, and The Role of Artificial Intell...
Faraz Pathan, Rubina Sheikh, Ayesha Siddiqua, Ashna Khan, Sana Malik, Prerona Das, ...
A Review on Role of Nanoparticles in Targeted Drug Delivery Systems ...
Komal Pawar, Suchita Lathi, Pallavi Shnide, Vaishnavi Shinde, ...